Table 2.

Adverse events after drug infusion



Treatment
Group 1Group 2
Symptoms
DDAVP; n
Eptifibatide and l-aspirin; n
Eptifibatide, l-aspirin, and DDAVP;n
Headache   4   2   4  
Hypotension*  3 (systemic)   3 (systemic)   5 (systemic)  
  8 (diastolic)   5 (diastolic)   7 (diastolic)  
Facial flush   1   0   2  
Nausea   1   0   0  
Thrombocytopenia
 
0
 
0
 
0
 


Treatment
Group 1Group 2
Symptoms
DDAVP; n
Eptifibatide and l-aspirin; n
Eptifibatide, l-aspirin, and DDAVP;n
Headache   4   2   4  
Hypotension*  3 (systemic)   3 (systemic)   5 (systemic)  
  8 (diastolic)   5 (diastolic)   7 (diastolic)  
Facial flush   1   0   2  
Nausea   1   0   0  
Thrombocytopenia
 
0
 
0
 
0
 
*

Hypotension was defined as a greater than 10% drop in blood pressure.

Thrombocytopenia was defined as less than 150 × 109/L.

or Create an Account

Close Modal
Close Modal